Concepedia

Eric Lewis

EL

Statistics

Publications

19

Citations

1.9K

H-Index

16

Active since

1986

Affiliations

Research Triangle Park Foundation(Current)

GlaxoSmithKline (United States)

Princess Margaret Cancer Centre

Icahn School of Medicine at Mount Sinai

University of Maryland, Baltimore

Eric Lewis is an author at Research Triangle Park Foundation specializing in pharmacology, medicine, and pharmacotherapy.

Publications per year

1986–2025

19

Publications

19

Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study

Sagar Lonial, Hans C. Lee, Ashraf Badros et al. · The Lancet Oncology · 2019 · 796 citations

, , +11

Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis

Amit Bar‐Or, Richard Grove, Daren Austin et al. · Neurology · 2018 · 214 citations · Full text

, , +15

The Antipsychotic Agent Sertindole is a High Affinity Antagonist of the Human Cardiac Potassium Channel HERG

David Rampe, Michael Murawsky, Eric Lewis · Journal of Pharmacology and Experimental Therapeutics · 1998 · 175 citations

, , +15

Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma

Vânia Hungria, Paweł Robak, Marek Hus et al. · New England Journal of Medicine · 2024 · 166 citations

, , +13

Longer term outcomes with single‐agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma: 13‐month follow‐up from the pivotal DREAMM‐2 study

Sagar Lonial, Hans C. Lee, Ashraf Badros et al. · Cancer · 2021 · 143 citations · Full text

, , +13

1–5 of 19